- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 655
Robinhood grabs another $50m
DST Global has invested $50m to boost Alphabet and Roc Nation-backed trading platform Robinhood’s series E round to $373m.
Oct 31, 2019CassTime cashes $80m in series C1 round
The Fosun-backed automotive services provider received $80m in a series C1 round co-led by Sequoia Capital China and Source Code Capital.
Oct 31, 2019Rokt racks up $48m
The Time-backed e-commerce marketing tool provider took its overall funding to $82m in a series C round where TDM Growth Partners joined existing investors.
Oct 31, 2019Timee clocks up $18.5m
The temporary employment service provider has completed a series B round backed by corporates including Mixi, Nexyz Group, Prologis, JR East, Kids Holdings, Gosso, WDI Corporation and SBS Holdings.
Oct 31, 2019Disc Medicine spins its way to $50m
Novo led the anaemia therapy developer's series A round, which also featured Access Industries subsidiary Access Biotechnology.
Oct 31, 2019Shuttl collects $42m
Toyota Tsusho paid $6.1m for a 3% stake in the bus aggregation service as part of a round that valued it at about $200m.
Oct 31, 2019Blade cuts out new financing
TheCharter Communications-backed PC gaming platform has secured $32.7m and revealed Western Digital invested earlier this year.
Oct 31, 2019Datameer sources $40m in new funding
Citi Ventures contributed to a late-stage round that will support the upgrading of data integration platform developer Datameer's sales and engineering resources.
Oct 31, 2019Kakehashi hashes out $24m from series B funding
The Japan-based medical startup has secured $24m in a series B round from corporates including Aflac, Dentsu, Globis, Itochu and Gree, which brought its total funding to over $30m.
Oct 31, 2019Sense Biodetection grasps $15.8m series A
Sense Biodetection has raised $15.8m in a series A round co-led by Cambridge Innovation Capital and Earlybird to produce a diagnostic test for infectious diseases.
Oct 31, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


